Global Amyotrophic Lateral Sclerosis Clinical Trials Review, H2, 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Amyotrophic
Lateral Sclerosis Global Clinical Trials Review, H2, 2018”
clinical trials has been added to ResearchAndMarkets.com’s
offering.

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2018″
provides an overview of Amyotrophic Lateral Sclerosis clinical trials
scenario. This report provides top line data relating to the clinical
trials on Amyotrophic Lateral Sclerosis. Report includes an overview of
trial numbers and their average enrollment in top countries conducted
across the globe.

The report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials). These reports are generated using a
proprietary database – Pharma eTrack Clinical trials database. Clinical
trials are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by
  Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
  End point status
• The report reviews top companies involved and enlists all trials
  (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated,
  Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Reasons to Buy

• Assists in formulating key business strategies with regards to
  investment
• Helps in identifying prominent locations for conducting clinical
  trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which
  helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by
  country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing
  a comparative scenario of completed and uncompleted (terminated,
  suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global,
  regional and country level

Key Topics Covered:

1. List of Tables & Figures
2. Report Guidance
3. Clinical Trials Report Coverage
4. Clinical Trials by Region
5. Clinical Trials and Average Enrollment by Country
6. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
7. Top Five Countries Contributing to Clinical Trials in Europe
8. Top Countries Contributing to Clinical Trials in North America
9. Top Countries Contributing to Clinical Trials in Middle East and Africa
10. Top Countries Contributing to Clinical Trials in Central and South
    America
11. Clinical Trials by G7 Countries: Proportion of Amyotrophic Lateral
    Sclerosis to Central Nervous System Clinical Trials
12. Clinical Trials by Phase in G7 Countries
13. Clinical Trials in G7 Countries by Trial Status
14. Clinical Trials by E7 Countries: Proportion of Amyotrophic Lateral
    Sclerosis to Central Nervous System Clinical Trials
15. Clinical Trials by Phase in E7 Countries
16. Clinical Trials in E7 Countries by Trial Status
17. Clinical Trials by Phase
18. In Progress Trials by Phase
19. Clinical Trials by Trial Status
20. Clinical Trials by End Point Status
21. Subjects Recruited Over a Period of Time
22. Clinical Trials by Sponsor Type
23. Prominent Sponsors
24. Top Companies Participating in Amyotrophic Lateral Sclerosis
    Therapeutics Clinical Trials
25. Prominent Drugs
26. Clinical Trial Profile Snapshots
27. Appendix

Companies Mentioned

• Cytokinetics Inc
• F. Hoffmann-La Roche Ltd
• Mitsubishi Chemical Holdings Corp
• Knopp Biosciences LLC
• Biogen Inc
• Teva Pharmaceutical Industries Ltd
• Newron Pharmaceuticals SpA
• AB Science SA
• GlaxoSmithKline Plc
• Flex Pharma Inc

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/frsi3i

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Central
Nervous System Drugs , Clinical
Trials